Loading...
0

Global Smart Inhalers Market is Expected to Reach $1,406 Million by 2026

 
 

quote The global smart inhalers market trends have gained momentum in the healthcare industry due to cost effectiveness and increased adherence to the treatment by patients owing to the presence of sensors attached to the inhalers, which stores data measuring the amount of dosage, increasing the efficiency of the drug. Recent developments such as product launches & approvals and collaborations & partnerships in the market by key players propel the market growth. quote

Onkar Sumant
Assistant Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, "Smart Inhalers Market by Product, Indication, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019 - 2026," the Global smart inhalers market size was valued to be at $34 million in 2018 and is expected to increase during the forecast period to be at $1,406 million by 2026, registering a CAGR of 58.4% from 2019 to 2026. The inhalers segment accounted for more than half of the total market share in 2018.

Smart inhalers are the small inhaler devices used for delivering several inhaled medications such as anticholinergics, glucocorticoids, and beta antagonists. According to CDC data of 2016, approximately 26.5 million people are living with asthma in the U.S., and nearly 1.7 million people were found out to be having asthma as the primary diagnosis during their visit to emergency departments. Smart inhalers contain sensors that are connected to inhaler devices, this allows maintaining the record of inhaler, increasing the adherence and monitoring of the patient.

The major factor attributing to the increase of smart inhalers is rise in prevalence of COPD and asthma, among which COPD is expected to be the third leading cause of death globally by 2030. Better treatment option, ease of use, and technological advancements coupled with increase in adherence rate of patients to smart inhalers are other major factors that drive this market. However, lack of reimbursement for smart inhalers and limited availability of smart inhalers in developing regions are expected to restrain the global smart inhalers market growth.

Currently, Adherium is the major player in this market with majority of the approved products being provided by Adherium. However, smart inhalers being a lucrative market, acquisitions and collaborations are increasing between the pharmaceutical companies and smart inhaler manufacturers. 

Based on distribution channel, the market is segmented into hospitals, retail pharmacies, and online pharmacies. Retail pharmacies segment is the highest contributor for the distribution channel segment. However, online pharmacies segment is the highest growing segment and is expected to propagate at a higher growth rate throughout the forecast period, owing to the preference over other pharmacies, as it provides hassle free doorstep delivery of the smart inhalers directly by the manufacturing companies.

Key Findings of the Smart Inhalers Market Study:

  • North America occupied more than one-third share of the global smart inhalers market in 2018.
  • The inhalers segment is the highest contributor in the product segment.
  • The online pharmacies in the distribution channel segment is anticipated to grow with the highest CAGR throughout the forecast period.
  • The hospitals in the distribution channel segment accounted for three-fourths share of the market in 2018. 
  • The nebulizers in the by product segment is anticipated to grow with the highest rate throughout the forecast period.
  • Asthma in by indication type segment accounted for the largest growth for the market.

This report provides a comprehensive analysis of the key players operating in this market. These include Adherium, Astrazeneca plc., Glaxo Smith Kline, Cohero Health Inc., Novartis International AG, ResMed Inc., Opko Health Inc., Boehringer Ingelheim Group, and Vectura Group plc.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Shaun Godinho
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Smart Inhalers Market by Product (Inhalers and Nebulizers), Indication (Asthma and COPD), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019 - 2026 quote

View Report
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Global Smart Inhalers Market"
Purchase Enquiry